I
FOLD

InceptionR’s Amicus Therapeutics FOLD Stock Holding History

InceptionR’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68,134
Closed -$537K – 687
2025
Q3 		$537K Buy
68,134
+57,485
+540% +$409K 0.13% 288
2025
Q2 		$61K Buy
+10,649
New +$68.7K 0.01% 623
2025
Q1 		– Sell
-13,778
Closed -$130K – 655
2024
Q4 		$130K Sell
13,778
-37,014
-73% -$385K 0.03% 579
2024
Q3 		$542K Buy
+50,792
New +$553K 0.13% 298
2023
Q1 		– Sell
-20,728
Closed -$253K – 483
2022
Q4 		$253K Buy
+20,728
New +$233K 0.13% 310

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

InceptionR's FOLD Position: Q4 2025 in Review

InceptionR sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 68,134 shares — an estimated $537K sold.

InceptionR first reported a position in FOLD in Q4 2022 and held it in 5 quarters. The position peaked at $542K in Q3 2024. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • InceptionR reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • InceptionR sold 68,134 Amicus Therapeutics shares in Q4 2025, an estimated $537K.
  • InceptionR first reported a position in Amicus Therapeutics in Q4 2022 and held it in 5 quarters.
  • InceptionR's Amicus Therapeutics position peaked at $542K in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on InceptionR's 13F filing for Q4 2025, filed 11 Feb 2026.